Returning for its 3rd year, Grand Rounds U.S. is the event to network with Pharmas, VCs, and Academic Innovators.
Early-stage translation at the academia-industry interface is one of the most complex and poorly leveraged spaces in biopharma, and Grand Rounds is built around it. This is a rare forum where translational science is explored in depth as its own discipline, across three concrete areas where bottlenecks most often emerge: emerging disease biology, discovery-enabling tools and technologies, and therapeutic modality design.
As a Life Science Washington community member, you’re already working at that early-stage drug and diagnostic development layer. What Grand Rounds offers is something genuinely uncommon: a room where you can talk science at that intersection with pharma and biotech executives, investors, academic innovators and founders, all engaging with translational challenges at the level of depth your work demands.
Register with our discount code: GR26LSW
Visit here for more information.